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Abstract
Background: Hemophilia A has the highest incidence, more than 80% of 172.323 cases worldwide in 2012. It is stated that clinical characteristics of hemophilia A is worse than others, so it is required to prove and to know further about the clinical characteristics and  severity likelihood in all hemophilic patients in order to prevent re-bleeding and re-injury and also for a better medical response.
Methods: A retrospective cross-sectional study was carried out to 43 medical records of hospitalized hemophilic patients from 2009 to 2013 in Dr Hasan Sadikin General Hospital. The inclusion criteria were a complete patient identity (name, age, sex), written chief complaint, complete physical examination (bleeding, edema, hematoma, hemarthrosis, anemic symptoms) and laboratory test results (factor level, hemoglobin, hematocrit, platelet and Activated Partial Thromboplastin Time). The data was  collected from 
August‒October 2014, analyzed and presented using frequency distribution.
Results: Most of the patients were 5-10 years old, male and had hemophilia A. The most common complaint 
was external bleeding, followed by edema. From 43 patients, 38 (88%) cases were classified as severe factor 
deficiency, had mild to severe anemia, however the platelet count in most of the cases was in normal value. About 91% cases had prolonged Activated Partial Thromboplastin Time in moderate to severe level.
Conclusions: Similar with other studies worldwide, most of the hospitalized hemophilic patients have hemophilia A. Most of the patents has moderate to severe bleeding with laboratory test result between moderate to severe level as well. [AMJ.2016;3(4):605–9]
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IntroductionHemophilia is an X-linked disease caused by mutation in sex chromosome resulting 
in protein deficiency named coagulation factors.1,2 Among several type of coagulation 
factors, deficiency factor VIII, IX, and XI 
occur in hemophilic patients. Deficiency of those factors contributed to a certain type of hemophilia, namely hemophilia A for factor 
VIII deficiency, hemophilia B for factor IX 
deficiency, and hemophilia C for factor XI 
deficiency.2 From 172.373 hemophilic cases worldwide in 2012, about 80% cases were hemophilia A, 16% cases were  hemophilia B, and the rest was hemophilia C and other bleeding disorders. Because it is an x-linked 
disease, hemophilia is more common found in male than female. Moreover,  incidence of this disease in children is quite high, about 1 in 5.000 children.3Furthermore, clinical manifestation in hemophilia is bleeding. Bleeding can occur spontaneously or is caused by any injury or surgery. Bleeding may happen in many parts of the body, usually it is found in gum, nose (epistaxis), skin (echymosis), and joints either in upper or lower extremities which may cause hematoma etc. Bleeding can also occur in vital organs such as kidney (causing hematuria), gastrointestinal tract (causing hematemesis), and the most dangerous bleeding is in the retroperitoneal space, causing blood accumulation in abdomen.4,6 
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Besides the bleeding sign, the patient will experience pain in joint, causing immobility. Additionally, laboratory abnormality also found such as factor level, sometimes hemoglobin, hematocrit level, and platelet 
deficiency, and also prolonged Activated Partial Thromboplastin Time (APTT).4 Currently, management for hemophilia is only limited by replacement therapy and symptomatic drugs, which means that there is 
no definitive therapy yet. So, aggravating sign and symptoms have to be prevented starting 
from the first time the patients come. One of the ways to provide better care is by knowing the characteristics of each clinical manifestation and the likelihood of severity. The aim of this study was to identify the severity likelihood of clinical manifestation in hemophilic patients.
MethodsA retrospective cross-sectional study was 
carried out during August-October 2014 at the 
Hemato-Oncology Child Health Department, Dr. Hasan Sadikin General Hospital Bandung. A total of 87 medical records of hospitalized hemophilic patients from 2009 to 2013 were succesfully collected, but only 43 (49.42%) medical records met the inclusion criteria, which were a complete patient identity (name, age, sex), written chief complaint, complete physical examination (bleeding, edema, hematoma, hemarthrosis, anemic symptoms) and laboratory test result (factor level, hemoglobin, hematocrit, platelet and APTT). Forty four samples (50.57%) were excluded due to incomplete data and having other chronic diseases affecting the laboratory result such as typhoid, dengue, meningitis, thalassemia, TBC, etc.7 
The data was collected from August‒
October 2014 and was classified into hemophilia A, B, and C. Next, characteristics of clinical manifestation based on the severity were distributed to each type of hemophilia. The result was a frequency distribution of each type of hemophilia with severity likelihood for every clinical manifestation and laboratory 
findings. Meanwhile, Ethical clearance has been approved by the Health Research Ethics Committee, Faculty of Medicine, Universitas Padjadjaran in order to access the patient medical records.
ResultMost of the hospitalized hemophilic patients 
Table 1 Characteristics and Type of 
  Hospitalized Hemophilic Patients
Characteristic and Type 
of Hemophilia
Total (%) 
(n=43)Age (years)
0‒4 14 (33)
5‒10 25 (58)
11‒14 4 (9)SexMale 42 (98)Female 1 (2)Type of HemophiliaHemophilia A 35 (81.4)Hemophilia B 4 (9.3)Hemophilia C 4 (9.3)
Table 2 Chief Complaint of Hospitalized 
   Hemophilic Patients (n=43)
Chief complaint Total (%)Bleeding (external) 25(58.14)Edema 12(27.90)Hematoma 4(9.30)Joint pain 1(2.33)Unconsciousness 1(2.33)Total 43(100%)
who met the inclusion criteria were 5-10 years old and male. In terms of the type of hemophilia, most of the patients had hemophilia A (Table 1). As mentioned in the introduction, the most common complaint of hemophilia is bleeding. This study showed that about 58.14% cases had external bleeding, followed by edema. Hematoma and joint pain only occurred in a small percentage (Table 2).
The factor level deficiency proved to be the main cause for hemophilic patients to experience bleeding. Among 43 patients, 38 
(88%) cases were classified as severe factor 
deficiency, In terms of bleeding severity, 19 (44%) cases were distributed in moderate level, the remaining (mild and severe level) was almost equally distributed. The hemophilic patients are commonly tested for anemic sign due to blood lost. The anemic state is seen from the result of the measurement of hemoglobin 
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and hematocrit level. Most of the cases had mild to severe anemia and only 42% cases had no anemia. This situation also occurred in hematocrit level. Moreover, the platelet count in most of the cases was in normal value. Moreover, an interesting result was discovered in this study, about 91% cases had prolonged APTT in moderate to severe level.
DiscussionThis study showed that most of the hospitalized hemophilic patients in Dr Hasan Sadikin General Hospital from 2009-2013 had hemophilia A. This result was similar with previous studies conducted by the World Federation for Hemophilia (WFH)3 and Josephson8 which stated that among the total of hemophilia patients, more than 80 % of them were hemophilia A. A study by Shawky et al.9 recorded that there were more Hemophilia A patients (6.26%) than hemophilia B patients (0.55%) at Pediatric clinic, Ain-Shams University hospitalin in Egypt.The most common clinical sign that become 
the chief complaint of the patients was external 
bleeding. This finding is similar with a study conducted by Liu et al.7Besides this study discovered the severity level of various laboratory test results. Most of 
the cases had severe factor deficiency. Similar result was discovered in a study carried out by the National Hemophilia Foundation (NHF)10. About 60–70% from the total hemophilic population worldwide is in the severe 
factor level deficiency. Regarding the type of hemophilia, a previous study by Liras et al.2 showed that 40% of cases of hemophilia A and hemophilia B, respectively, contributes to 
severe level of factor deficiency. In this study, about 75–80% of patients for each type was 
distributed in the severe level. On the other hand, another study conducted by Ghaniema et al.11 showed a different result. They mentioned that 60% of their samples were in 
the moderate level of factor deficiency.Moreover, the bleeding sign was also 
classified into mild, moderate and severe level. The bleeding sign for hemophilic patients who were hospitalized in Dr. Hasan Sadikin General 
Table 3 Clinical Manifestation and Laboratory Findings based on Type of Hemophilia 
Clinical 
Manifestation Severity
Hemophilia
Total
A(%) B(%) C(%)Factor Level Mild (6‒46%) 1 (2) - - 1 (2)
Moderate (1‒5%) 3 (7) 1 (2) - 4 (9)Severe (<1%) 31 (72) 3 (7) 4 (9) 38 ( 88)Bleeding Mild (no spontaneous bleeding) 11 (26) 1 (2) - 12 (28)Moderate (sometimes spontaneous bleeding) 13 (30) 3 (7) 3 (7) 19 (44)Severe (often spontaneous bleeding) 11 (26) - 1 (2) 12 (28)Hemoglobin level Normal (≥115 g/l) 15 (35) 1 (2) 2 (5) 18 (42)
Mild (110‒114 g/l) 2 (5) 1 (2) - 3 (7)
Moderate (80‒109 g/l) 4 (9) 2 (5) 1 (2) 7  (16)
Severe (≤80 g/l) 14 (33) - 1 (2) 15 (35)Hematocrit level Normal (35‒48%) 10 (23) 1 (2) 2 (5) 13 (30)
Mild (32‒35%) 9 (21) - - 9 (21)
Moderate (28‒32%) 2 (5) 2 (5) - 4 (7)Severe (<28%) 14 (33) 1 (2) 2 (5) 17 (40)Platelet level Normal (150.000‒450.000/mm3) 25 (58) - 3 (7) 28 (65)Increase (>450.000/mm3) 10 (23) 4 (9) 1 (2) 15 (34)APTT Normal (18‒28 second) 1 (2) - 1 (2) 2 (4)Mild (<40 second) 1 (2) 1 (2) - 2 (4)Moderate to severe (>40 second) 33 (77) 3 (7) 3 (7) 39 (91)
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Hospital from 2009 to 2013 was distributed in moderate level. This study showed that most of the Hemophilia A cases had moderate to severe level of bleeding compared to the Hemophilia B cases that had mild to moderate level of bleeding severity. Additionally, Fasulo et al.12 stated that hemophilia B had a milder manifestation than hemophilia A.Another laboratory test for hemophilia patients was the measurement of hemoglobin level. This study discovered that most of the patients had mild to severe level of anemia, although there were still 42% cases that had 
no anemia. Besides, significant hemoglobin and hematocrit level decrement resulted in anemic sign and were related to bleeding sign. A previous study conducted by Buchanan and Holtkamp13 stated that hemoglobin level decrement could occur in hemophilic patients, while in fact, blood lost due to bleeding in hemophilia rarely causes anemia. There was another factor causing anemia in hemophilia cases which was still unknown. The number of patients with a normal platelet level was higher than a decreased or increased platelet level. The interesting 
finding discovered in this study was that the platelet level mostly increased. A study conducted by Yee14 stated that the platelet level decrement likelihood would be found in severe hemophilia unless hemophilia is still in a mild stage.Furthermore, APPT prolongation occurred in most cases. This condition occurred due 
to the severity of factor level deficiency or 
bleeding. If the factor level deficiency and bleeding sign were in severe level, it would 
cause significant APTT prolongation. Previous studies conducted by Tantawy6 and Cuker et al.15 stated that APTT would be normal in mild hemophilia while prolonged APTT would be found in severe hemophilia.This study still had limitations. The 
sample size was very  small, so it was difficult to compare the severity of each type of hemophilia. Moreover, this study was carried out in a  top referral hospital so it was suspected that most cases which came to this hospital were  already in the moderate to severe state.It can be concluded that most of the hospitalized hemophilic patients has hemophilia A. Most of the patients has moderate to severe bleeding with laboratory test result between moderate to severe level as well.
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